Company Monitoring Page for Allergan

latest headlines for company on cafepharma

Amgen, Allergan step up to challenge Roche's Avastin with FDA biosim filing
Fierce Pharma
Wed, 11/16/16 - 09:57 am
Tags:
Amgen, Allergan, Roche, Avastin, biosimilars, FDA, ABP 215
Allergan's Restasis Faces Dry Eye Threat: Examining XIIDRA's Initial Sales Trends
Seeking Alpha
Tue, 11/8/16 - 10:09 am
Tags:
Allergan, dry eye disease, Restasis, Xiidra, Shire
1 Reason Behind Allergan's Dreadful October
Motley Fool
Tue, 11/8/16 - 09:57 am
Tags:
Allergan, drug pricing
3 Things You Really Need to Know About Allergan's Q3 Results
Motley Fool
Wed, 11/2/16 - 09:43 pm
Tags:
Allergan, earnings
Allergan Successfully Completes Tobira Therapeutics Acquisition
Yahoo
Tue, 11/1/16 - 04:53 pm
Tags:
Allergan, Tobira Therapeutics, M&A
Allergan’s executive team orchestrates a $200M buyout to beef up gastroenterology pipeline
Endpoints
Thu, 10/27/16 - 09:22 am
Tags:
Allergan, M&A, relamorelin, diabetic gastroparesis
Allergan urological drug gets thumbs up from FDA panel
BioPharma Dive
Sat, 10/22/16 - 03:15 pm
Tags:
Allergan, FDA, SER-120, Serenity Pharmaceuticals
Allergan May Have Outbid Gilead For Tobira, Setting The Backdrop For A Showdown In NASH
Seeking Alpha
Wed, 10/19/16 - 10:44 am
Tags:
Allergan, Gilead Sciences, Tobira, NASH, Cenicriviroc
Pfizer Loses U.K. Patent Appeal Over $4.8 Billion Lyrica Drug
Bloomberg
Thu, 10/13/16 - 10:59 am
Tags:
Pfizer, UK, patents, Lyrica, Allergan, Actavis
Allergan Enters the Attractive NASH Market
Market Realist
Thu, 10/6/16 - 09:26 am
Tags:
Allergan, NASH, Cenicriviroc, Tobira Therapeutics
AstraZeneca hands off another Amgen-partnered drug in a $1.5B deal with an acquisitive Allergan
Endpoints
Mon, 10/3/16 - 10:09 am
Tags:
AstraZeneca, Amgen, Allergan, MEDI2070, ulcerative colitis, Crohn's Disease
Why Pfizer's Scrapped Merger May Ultimately Benefit the Company and Investors
TheStreet.com
Sun, 10/2/16 - 10:24 am
Tags:
Pfizer, M&A, Allergan
Allergan wins FDA nod for Natrelle Inspira breast implants
Mass Device
Mon, 09/26/16 - 03:19 pm
Tags:
Allergan, FDA, breast implants, devices, Natrelle Inspira
Will Gilead Make a Good Fit for Allergan?
Investopedia
Fri, 09/23/16 - 09:56 am
Tags:
Gilead Sciences, Allergan, M&A
Allergan CEO says 'the American people deserve to be angry' at price gouging
CNBC
Thu, 09/22/16 - 09:24 am
Tags:
Allergan, Brent Saunders, drug pricing
Biotech: Why NASH is So Hot Right Now
Barron's
Wed, 09/21/16 - 10:55 pm
Tags:
NASH, Allergan, M&A, Gilead Sciences, Tobira Therapeutics, Galmed Pharmaceuticals
Allergan Going After Gilead? Gabelli Says CEO 'Playing Chess While The Market Is Playing Checkers'
Yahoo/Benzinga
Wed, 09/21/16 - 10:51 pm
Tags:
Allergan, Gilead Sciences, M&A
Allergan just acquired two companies in one day
Yahoo/Business Insider
Tue, 09/20/16 - 08:54 pm
Tags:
Allergan, M&A, liver disease, NASH, Akarna Therapeutics, Tobira Therapeutics
Allergan pays $50 mln to buy privately-held Akarna Therapeutics
Marketwatch
Tue, 09/20/16 - 08:42 pm
Tags:
Allergan, Akarna Therapeutics, M&A, NASH
Allergan Buys Tobira for Up to $1.7 Billion to Gain Liver Drug
Bloomberg
Tue, 09/20/16 - 09:54 am
Tags:
Allergan, Tobira Therapeutics, M&A, NASH

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.